PapersPMID:40089929
Salvia miltiorrhiza adjuvant therapy facilitates cardiac function recovery in patients with myocardial infarction.
What moved
1 findingHow to read these marks →- Increases left ventricular ejection fraction
very limited
“After two weeks, the SM group demonstrated significantly increased left ventricular ejection fraction (LVEF) and reduced left ventricular end-systolic and end-diastolic diameters (LVESD, LVEDD) compared to RT (P<0.001).”
- Study
- RCT
- Dose studied
- Salvia miltiorrhiza injection added to routine treatment; dose and route not stated in the abstract
- Population
- 120 patients with acute myocardial infarction; both arms received routine treatment (RT), the intervention arm had Salvia miltiorrhiza injection added
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Patients with acute myocardial infarction; abstract only; Salvia miltiorrhiza (SM) injection added to routine treatment (RT) versus RT alone
- Participants
- 120
- Comparator
- no treatment / not stated in the paper
- Duration
- not reported
- Endpoints measured
- 8